SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022937
Filing Date
2020-05-07
Accepted
2020-05-07 16:37:19
Documents
49
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 Q1 2020 10-Q snss-10q_20200331.htm 10-Q 1370805
2 EX-4.1 snss-ex41_109.htm EX-4.1 28397
3 EX-10.1 SVB DEFERRAL AGREEMENT snss-ex101_90.htm EX-10.1 123246
4 EX-31.1 snss-ex311_8.htm EX-31.1 16722
5 EX-32.1 snss-ex321_6.htm EX-32.1 6748
6 GRAPHIC gsusaoncj2yf000001.jpg GRAPHIC 74193
7 GRAPHIC g1dv1muffbih000001.jpg GRAPHIC 3336
  Complete submission text file 0001564590-20-022937.txt   4109686

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT snss-20200331.xml EX-101.INS 603351
9 XBRL TAXONOMY EXTENSION SCHEMA snss-20200331.xsd EX-101.SCH 35311
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20200331_cal.xml EX-101.CAL 40633
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20200331_def.xml EX-101.DEF 101406
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20200331_lab.xml EX-101.LAB 278720
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20200331_pre.xml EX-101.PRE 190444
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 20857069
SIC: 2834 Pharmaceutical Preparations